Efficacy of alendronate in the treatment of the SAPHO syndrome.
Department of Clinical Medicine and Immunologic Sciences, Policlinico Le Scotte, University of Siena, Siena, Italy.
Antonella
A
Fioravanti
Luca
L
Cantarini
Luca
L
Burroni
Maria Antonietta
MA
Mazzei
Luca
L
Volterrani
Mauro
M
Galeazzi
D020083:Acquired Hyperostosis Syndrome / Q000188:drug therapy*; D000328:Adult; D019386:Alendronate / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans
D050071:Bone Density Conservation Agents; D019386:Alendronate